Modelling the cost-effectiveness of cervical cancer screening with HPV self-sampling and molecular triage for women aged 60–69 years
Molecular triage, whether used with self-sampling or professional sampling, does not appear cost-effective for identifying HSIL in this age group compared to the current screening strategy.
Authors
- Gabriella Lillsunde‐Larsson (ORCID: https://orcid.org/0000-0001-9992-266X)
- Lovisa Bergengren (ORCID: https://orcid.org/0000-0002-1458-1542)
- Linda Ryen (ORCID: https://orcid.org/0000-0003-4048-185X)
- Jasmine Fridljung
Institutions
- Örebro University (SE)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-05-18
- DOI
- https://doi.org/10.1007/s12672-025-02432-3
- Citations
- 1
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Örebro Universitet
- Universitetssjukhuset Örebro